NCGC 84
| SMILES | Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 |
| InChIKey | VSWYSDPXUHVQCG-DTQAZKPQSA-N |
Chemical properties
| Hydrogen bond acceptors | 2 |
| Hydrogen bond donors | 0 |
| Rotatable bonds | 6 |
| Molecular weight (Da) | 465.2 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 6.65 | 6.65 | 6.65 | ChEMBL |
| M5 | ACM5 | Human | Acetylcholine (muscarinic) | A | pKi | 6.29 | 6.29 | 6.29 | ChEMBL |
| β3 | ADRB3 | Human | Adrenoceptors | A | pKi | 5.69 | 5.69 | 5.69 | ChEMBL |
| M4 | ACM4 | Human | Acetylcholine (muscarinic) | A | pKi | 6.07 | 6.07 | 6.07 | ChEMBL |
| α2A | ADA2A | Human | Adrenoceptors | A | pKi | 6.25 | 6.25 | 6.25 | ChEMBL |
| M3 | ACM3 | Human | Acetylcholine (muscarinic) | A | pKi | 5.94 | 5.94 | 5.94 | ChEMBL |
| M2 | ACM2 | Human | Acetylcholine (muscarinic) | A | pKi | 6.09 | 6.09 | 6.09 | ChEMBL |
| M1 | ACM1 | Human | Acetylcholine (muscarinic) | A | pKi | 5.93 | 5.93 | 5.93 | ChEMBL |
| 5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 5.55 | 5.55 | 5.55 | ChEMBL |
| κ | OPRK | Human | Opioid | A | pKi | 6.93 | 6.93 | 6.93 | ChEMBL |
| μ | OPRM | Human | Opioid | A | pKi | 6.99 | 6.99 | 6.99 | ChEMBL |
| H2 | HRH2 | Human | Histamine | A | pKi | 5.53 | 5.53 | 5.53 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| NPS | NPSR1 | Human | Neuropeptide S | A | pA2 | 8.98 | 8.98 | 8.98 | Guide to Pharmacology |
| CX3CR1 | CX3C1 | Human | Chemokine | A | pIC50 | 5.21 | 5.21 | 5.21 | ChEMBL |
| GPR35 | GPR35 | Human | Orphan | A | pIC50 | 5.38 | 5.38 | 5.38 | ChEMBL |
| FPR1 | FPR1 | Human | Formylpeptide | A | pIC50 | 4.77 | 4.77 | 4.77 | ChEMBL |
| GPR119 | GP119 | Human | GPR18, GPR55 and GPR119 | A | pIC50 | 5.26 | 5.26 | 5.26 | ChEMBL |
| AT1 | AGTR1 | Human | Angiotensin | A | pIC50 | 5.38 | 5.38 | 5.38 | ChEMBL |
| α2A | ADA2A | Human | Adrenoceptors | A | pIC50 | 5.4 | 5.4 | 5.4 | ChEMBL |
| M2 | ACM2 | Human | Acetylcholine (muscarinic) | A | pIC50 | 5.49 | 5.49 | 5.49 | ChEMBL |
| NPS | NPSR1 | Human | Neuropeptide S | A | Potency | 6.41 | 6.88 | 7.36 | ChEMBL |
| NPS | NPSR1 | Human | Neuropeptide S | A | pIC50 | 7.35 | 8.43 | 9.02 | ChEMBL |
| μ | OPRM | Human | Opioid | A | pIC50 | 6.24 | 6.24 | 6.24 | ChEMBL |
| apelin | APJ | Human | Apelin | A | pIC50 | 5.18 | 5.18 | 5.18 | ChEMBL |
| FPR3 | FPR3 | Human | Formylpeptide | A | pIC50 | 5.41 | 5.41 | 5.41 | ChEMBL |
| S1P1 | S1PR1 | Human | Lysophospholipid (S1P) | A | pIC50 | 5.47 | 5.47 | 5.47 | ChEMBL |
| GPR183 | GP183 | Human | Orphan | A | pIC50 | 5.32 | 5.32 | 5.32 | ChEMBL |
| ADGRF1 | AGRF1 | Human | ADGRF | B2 | pIC50 | 5.3 | 5.3 | 5.3 | ChEMBL |